Drug Device Combination Products Market 2021: Industry Analysis, Overview, Trends, Growth, Price and Forecast 2026
According to the latest
report by IMARC Group, titled “Drug
Device Combination Products Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2021-2026,” the market to grow at a CAGR of XX% during 2021-2026.
Drug device combination
products include medical devices and pharmaceutical ingredients that help
deliver the drug to a preferred location in the patient’s body. They comprise
drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems,
and prefilled syringes. They have minimal side effects and offer advantages
like controlled drug administration and improved patient compliance.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Drug Device
Combination Products Market Trends:
The growing prevalence of
chronic diseases, such as asthma, cancer, diabetes, and cardiovascular
disorders, represents one of the key factors driving the market. Moreover,
rising preferences for smart and precision drug delivery systems, which
minimize the amount of drug required for therapeutic efficacy, are driving the
demand for drug device combination products across the globe. Besides this,
several market players are introducing advanced technologies for tracking and
monitoring different products. They are also expending on extensive research
and development (R&D) activities to develop next-generation products with
high viscosity and formulations. Furthermore, the growing popularity of
minimally invasive surgery (MIS) and portable devices like nebulizers and
inhalers are other growth-inducing factors positively influencing the market.
Request
Free Sample Report: https://www.imarcgroup.com/drug-device-combination-products-market/requestsample
Drug Device
Combination Products Market 2021-2026 Analysis and Segmentation:
Competitive
Landscape:
The competitive landscape
of the market has been studied in the report with the detailed profiles of the
key players operating in the market.
Abbott Laboratories, Baxter
International Inc., Bayer AG, Becton Dickinson and Company, Boston Scientific
Corporation, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc,
Novartis AG, Smith & Nephew plc, Stryker Corporation and Terumo
Corporation.
The report has segmented
the market on the basis on region, disc type, material type and end user.
Breakup
by Product:
- Drug
Eluting Stents
- Transdermal
Patches
- Infusion
Pumps
- Drug
Eluting Balloon
- Inhalers
- Others
Breakup
by Application:
- Cardiovascular
- Diabetes
- Cancer Treatment
- Respiratory Diseases
- Others
Breakup
by End User:
·
Hospitals
·
Ambulatory
Surgical Centers
·
Others
Breakup
by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
·
Middle East and Africa
Ask
Analyst for Customization and Explore Full Report with TOC & List of
Figure: https://www.imarcgroup.com/drug-device-combination-products-market
Key
highlights of the report:
- Market Performance
(2015-2020)
- Market Outlook
(2021-2026)
- Porter’s Five Forces
Analysis
- Market Drivers and
Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping
of the Competitive Landscape
If you need specific
information that is not currently within the scope of the report, we can
provide it to you as a part of the customization.
If you want latest primary
and secondary data (2021-2026) with Cost Module, Business Strategy,
Distribution Channel, etc. Click request free sample report, published report
will be delivered to you in PDF format via email within 24 to 48 hours of
receiving full payment.
About Us
IMARC Group is a leading
market research company that offers management strategy and market research
worldwide. We partner with clients in all sectors and regions to identify their
highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information
products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high
technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact
Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800,
+91-120-433-0800
Comments
Post a Comment